NEW
YORK, June 18, 2024 /PRNewswire/ -- The
global pneumonia testing market size is estimated to grow
by USD 807.5 million from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 5.69% during the forecast period. Rising prevalence
of pneumonia and concerns associated with pneumonia
mortality is driving market growth, with a trend
towards growing importance of promotional activities.
However, poor healthcare infrastructure in developing
economies poses a challenge. Key market players include
Abbott Laboratories, Acumen Diagnostics Pte Ltd., Becton Dickinson and Co., bioMerieux SA, Bio Rad
Laboratories Inc., Danaher Corp., Diamedica SIA, DiaSorin SpA, F.
Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. Of America
Holdings, LGC Science Group Holdings Ltd., Meridian Bioscience
Inc., OpGen Inc., Pfizer Inc., Quest Diagnostics Inc., Quidelortho
Corp., Siemens AG, Thermo Fisher Scientific Inc., and Trinity
Biotech Plc.
Get a detailed analysis on regions, market segments, customer
landscape, and companies- View the snapshot of this report
Pneumonia Testing
Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
5.69%
|
Market growth
2024-2028
|
USD 807.5
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
5.3
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
31%
|
Key
countries
|
US, China, Germany, UK,
and Japan
|
Key companies
profiled
|
Abbott Laboratories,
Acumen Diagnostics Pte Ltd., Becton Dickinson and Co., bioMerieux
SA, Bio Rad Laboratories Inc., Danaher Corp., Diamedica SIA,
DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory
Corp. Of America Holdings, LGC Science Group Holdings Ltd.,
Meridian Bioscience Inc., OpGen Inc., Pfizer Inc., Quest
Diagnostics Inc., Quidelortho Corp., Siemens AG, Thermo Fisher
Scientific Inc., and Trinity Biotech Plc
|
Market Driver
The diagnostic market for pneumonia tests faces unique
challenges due to the specialized nature of the products and
limited end-user awareness. Vendors focus on expanding distribution
networks and increasing product availability. Thermo Fisher
Scientific and Bio-Rad Laboratories utilize YouTube channels for
product explanation, reaching 140.84 million and 1.2 million
subscribers, respectively. Non-profit organizations conduct
workshops to enhance awareness. Market growth is anticipated as
vendors recognize the importance of promotional
activities.
The pneumonia testing market is experiencing significant growth
due to the increasing number of cases worldwide. Lung functions,
cultures, and imaging tests such as X-rays and CT scans are
commonly used for diagnosis. Preventive measures like vaccines and
antimicrobial treatments are crucial in managing this condition.
The market for point-of-care tests is expanding, providing quicker
and more accurate results. Additionally, advances in technology,
like artificial intelligence and machine learning, are improving
diagnostic accuracy and efficiency. Overall, the pneumonia testing
market is a vital sector in healthcare, ensuring early detection
and effective treatment.
Research report provides comprehensive data on impact of trend.
For more details- Download a Sample Report
Market Challenges
- In developing economies, limited healthcare infrastructure and
budget constraints hinder the widespread use of advanced medical
devices for pneumonia testing. Countries like India, China,
and Brazil face healthcare
challenges, including disparities in access to resources and
increased patient dissatisfaction. The lack of research and
development in cost-effective technologies and medical devices
further hinders market growth. During the COVID-19 pandemic, the
shortage of devices like pulse oximeters, ventilators, and BiPAP
machines led to higher mortality rates among COVID-19 patients.
Inadequate healthcare infrastructure and services result in lower
quality treatment and lower life expectancy, reducing the need for
pneumonia testing devices.
- The Pneumonia Testing Market faces several challenges in
providing accurate and timely diagnoses. Antibiotics and fungal
agents are common causes of pneumonia, requiring specific testing
methods. Consumptives and chronic obstructive pulmonary disease
patients are at risk, making early detection crucial. However,
current tests such as chest X-rays and blood tests have
limitations. Culture and sensitivity tests take time, while rapid
tests may not be sensitive enough. Additionally, point-of-care
tests for specific pathogens are not widely available. To address
these challenges, research and development efforts are focused on
creating more accurate and faster testing methods, including
molecular and biomarker-based tests. These advancements could
significantly improve patient outcomes and reduce healthcare
costs.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This pneumonia testing market report extensively covers market
segmentation by
- Product Type
- 1.1 Consumables
- 1.2 Analyzers
- Method
- 2.1 Immunodiagnostics
- 2.2 Molecular diagnostics
- 2.3 Point-of-care testing
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Consumables- The Pneumonia Testing Market
involves the use of various consumables for detecting
contamination, including kits and reagents such as PCR assays,
nucleic acid detection kits, staining materials, elimination kits
and reagents, standards, and controls. Vendors like Meridian
Bioscience Inc. Provide reliable pneumonia detection kits with
repurchasable assays. Companies develop assays to detect different
pneumonia species, which can cause up to 95% of cell culture
contamination. Highly sensitive and rapid detection methods, like R
and D Systems' MycoProbe kit, are preferred due to pneumonia's
resistance to antibiotics. The market's growth is driven by vendors
introducing new consumables and their adoption by end-users.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data
(2017-2021) - Download a Sample Report
Research Analysis
The Pneumonia Testing Market encompasses various diagnostic
tools and techniques for the detection of pneumonia in both the
geriatric population and children. Traditional methods, such as
cultures, although effective, are time-consuming and come with a
high error rate. The healthcare industry is witnessing a shift
towards more advanced technologies, including nucleic acid
detection and immunofluorescence, for faster and more accurate
results. Factors contributing to the rising demand for pneumonia
testing include the prevalence of pneumonia, sedentary lifestyles,
unhealthy food habits, and environmental factors. The Pneumonia
Testing Industry is witnessing significant growth due to the
increasing healthcare expenditure and the need for reimbursements.
Point-of-care (POC) testing and analyzers are gaining popularity
due to their convenience and cost-effectiveness. Guidelines from
organizations like the American Thoracic Society (ATS), Infectious
Diseases Society of America (IDSA), and the CAP are driving the
development of new technologies for pneumonia diagnostics.
Companies are investing in the production of consumables for these
advanced testing methods, with Curetis and GE Healthcare being
notable contributors in the field of pneumonia diagnostics. The
Thoracic Care Suite from GE Healthcare, for instance, is a
comprehensive solution for the diagnosis and treatment of
pneumonia, featuring tests for Streptococcus pneumoniae and other
common pathogens. The prevalence of pneumonia, particularly in the
elderly population, is a significant concern, making the
advancements in pneumonia testing a crucial development in the
healthcare sector.
Market Research Overview
The Pneumonia Testing Market encompasses various diagnostic
techniques used to identify and distinguish different types of
pneumonia. These tests include culture and sensitivity, chest
X-ray, blood tests, and imaging techniques such as CT scans and
MRI. The market is driven by the increasing prevalence of
pneumonia, particularly in the elderly and those with underlying
health conditions. Additionally, the growing awareness of early
diagnosis and treatment, as well as advancements in diagnostic
technology, are contributing to market growth. The market is
segmented based on product type, end-user, and region. The global
Pneumonia Testing Market is expected to grow significantly in the
coming years due to these factors.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product Type
-
- Method
-
- Immunodiagnostics
- Molecular Diagnostics
- Point-of-care Testing
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pneumonia-testing-market-size-is-set-to-grow-by-usd-807-5-million-from-2024-2028--rising-prevalence-of-pneumonia-and-concerns-associated-with-pneumonia-mortality-boost-the-market-technavio-302175316.html
SOURCE Technavio